Tags |
|
|
Links |
|
|
Main Subject - Creativity and Innovation Management: Specialisation or Generalisation?
Creativity can be defined as problem identification and idea generation whilst innovation can be defined as idea selection
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
, development and commercialisation.
There are other useful definitions in this field, for example, creativity can be def
There are other useful definitions in this field, for example, creativity can be def
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ned as consisting of a number of ideas, a number of diverse ideas and a number of novel ideas.
There are distinct process
There are distinct process
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
s that enhance problem identification and idea generation and, similarly, distinct processes that enhance idea selection,
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
evelopment and commercialisation. Whilst there is no sure fire route to commercial success, these processes improve the pr
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
bability that good ideas will be generated and selected and that investment in developing and commercialising those ideas
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ill not be wasted.
Specialisation versus Generalisation
One of the topics often debated is the benefit of special
Specialisation versus Generalisation
One of the topics often debated is the benefit of special
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
sation over generalisation. To consistently generate a large number of good ideas, is it better to specialise within a fie
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
d or to vary knowledge amongst a variety of fields?
Sternberg (1999), along with other theorists, argues that in-depth kn
Sternberg (1999), along with other theorists, argues that in-depth kn
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
wledge of a domain does not always lead to good ideas but such knowledge does seem to be a necessary condition for them. G
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
over (1989) identified only three notably works produced before year ten of a composer’s career, indicating that substanti
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
l practice or establishment in the field was initially required. West (1995) points out that the vast majority of gains ar
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
made with the further application of what is already known.
However, Einstein said that the hardest thing he had to do w
However, Einstein said that the hardest thing he had to do w
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
s unlearn what he had learned.
Others counter that specialisation leads to path dependency and parochialism.
Still other
Others counter that specialisation leads to path dependency and parochialism.
Still other
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
point out that what is important is a range of tacit knowledge – experience in multiple fields that allows intellectual c
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
oss pollination, that is the raw material for good idea generation.
These topics are covered in depth in the MBA disserta
These topics are covered in depth in the MBA disserta
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ion on Managing Creativity & Innovation, which can be purchased (along with a Creativity and Innovation DIY Audit, Good Id
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
a Generator Software and Power Point Presentation) from http:/
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
www.managing-creativity.com/
You can also receive a regular, free newsletter by entering your email address at this s
You can also receive a regular, free newsletter by entering your email address at this s
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
te.
You are free to reproduce this article as long as no changes are made and the author's name and site URL are retained
You are free to reproduce this article as long as no changes are made and the author's name and site URL are retained
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/24234/mainsubjects-Creativity-and-Innovation-Management--Specialisation-or-Generalisation.html">Creativity and Innovation Management: Specialisation or Generalisation?</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/24234/mainsubjects-Creativity-and-Innovation-Management--Specialisation-or-Generalisation.html]Creativity and Innovation Management: Specialisation or Generalisation?[/url]
Related Articles:
Internet Business Tip - Why Are You Reading When You Should Be Writing?
Bookmark it:
|